Which has stronger valuation & earnings, DXCM or ABT?

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.00 $836.30M $2.34 30.97 Abbott Laboratories $44.33B 3.48 $6.52B $3.57 24.78

Is DXCM or ABT more profitable?

DexCom has a net margin of 19.31% compared to Abbott Laboratories' net margin of 13.90%. DexCom's return on equity of 33.33% beat Abbott Laboratories' return on equity. Company Net Margins Return on Equity Return on Assets DexCom 19.31% 33.33% 13.19% Abbott Laboratories 13.90% 17.62% 10.01%

Does the media refer more to DXCM or ABT?

In the previous week, Abbott Laboratories had 32 more articles in the media than DexCom. MarketBeat recorded 55 mentions for Abbott Laboratories and 23 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.41 beat DexCom's score of 1.14 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 17 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ABT or ISRG?

In the previous week, Intuitive Surgical had 15 more articles in the media than Abbott Laboratories. MarketBeat recorded 70 mentions for Intuitive Surgical and 55 mentions for Abbott Laboratories. Intuitive Surgical's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.41 indicating that Intuitive Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Intuitive Surgical 65 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to ABT or TSLA?

In the previous week, Tesla had 189 more articles in the media than Abbott Laboratories. MarketBeat recorded 244 mentions for Tesla and 55 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.41 beat Tesla's score of 0.96 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tesla 165 Very Positive mention(s) 26 Positive mention(s) 33 Neutral mention(s) 17 Negative mention(s) 3 Very Negative mention(s) Positive

Is ABT or ABBV more profitable?

Abbott Laboratories has a net margin of 13.90% compared to AbbVie's net margin of 5.79%. Abbott Laboratories' return on equity of 17.62% beat AbbVie's return on equity. Company Net Margins Return on Equity Return on Assets Abbott Laboratories 13.90% 17.62% 10.01% AbbVie 5.79% -576.45% 13.39%

Does the media refer more to ABT or ABBV?

In the previous week, AbbVie had 7 more articles in the media than Abbott Laboratories. MarketBeat recorded 62 mentions for AbbVie and 55 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.41 beat AbbVie's score of 1.19 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AbbVie 49 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer BSX or ABT?

In the previous week, Abbott Laboratories had 5 more articles in the media than Boston Scientific. MarketBeat recorded 55 mentions for Abbott Laboratories and 50 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.52 beat Abbott Laboratories' score of 1.41 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Abbott Laboratories (ABT) Competitors

$88.48 +0.07 (+0.08%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$88.32 -0.17 (-0.19%)

As of 06/18/2026 07:57 PM Eastern

Compare

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

Should you buy Abbott Laboratories stock or one of its competitors? MarketBeat compares Abbott Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Abbott Laboratories include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), and Boston Scientific (BSX).

How does Abbott Laboratories compare to DexCom?

DexCom (NASDAQ:DXCM) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.00	$836.30M	$2.34	30.97
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78

In the previous week, Abbott Laboratories had 32 more articles in the media than DexCom. MarketBeat recorded 55 mentions for Abbott Laboratories and 23 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.41 beat DexCom's score of 1.14 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	17 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DexCom has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

DexCom presently has a consensus price target of $84.83, suggesting a potential upside of 17.06%. Abbott Laboratories has a consensus price target of $118.30, suggesting a potential upside of 33.71%. Given Abbott Laboratories' higher possible upside, analysts plainly believe Abbott Laboratories is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85

97.8% of DexCom shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

DexCom has a net margin of 19.31% compared to Abbott Laboratories' net margin of 13.90%. DexCom's return on equity of 33.33% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Abbott Laboratories	13.90%	17.62%	10.01%

Summary

DexCom beats Abbott Laboratories on 9 of the 16 factors compared between the two stocks.

How does Abbott Laboratories compare to Intuitive Surgical?

Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Abbott Laboratories has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

Intuitive Surgical has a net margin of 28.15% compared to Abbott Laboratories' net margin of 13.90%. Abbott Laboratories' return on equity of 17.62% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Intuitive Surgical	28.15%	15.98%	14.07%

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78
Intuitive Surgical	$10.06B	14.31	$2.86B	$8.25	49.31

Abbott Laboratories presently has a consensus price target of $118.30, indicating a potential upside of 33.71%. Intuitive Surgical has a consensus price target of $573.42, indicating a potential upside of 40.96%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.6% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Intuitive Surgical had 15 more articles in the media than Abbott Laboratories. MarketBeat recorded 70 mentions for Intuitive Surgical and 55 mentions for Abbott Laboratories. Intuitive Surgical's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.41 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Intuitive Surgical	65 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Intuitive Surgical beats Abbott Laboratories on 11 of the 16 factors compared between the two stocks.

How does Abbott Laboratories compare to Tesla?

Abbott Laboratories (NYSE:ABT) and Tesla (NASDAQ:TSLA) are related large-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Abbott Laboratories has a beta of 0.63, indicating that its share price is 37% less volatile than the broader market. Comparatively, Tesla has a beta of 1.8, indicating that its share price is 80% more volatile than the broader market.

Abbott Laboratories has a net margin of 13.90% compared to Tesla's net margin of 3.95%. Abbott Laboratories' return on equity of 17.62% beat Tesla's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Tesla	3.95%	4.89%	2.93%

Abbott Laboratories currently has a consensus price target of $118.30, suggesting a potential upside of 33.71%. Tesla has a consensus price target of $404.37, suggesting a potential upside of 0.97%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities research analysts plainly believe Abbott Laboratories is more favorable than Tesla.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85
Tesla	5 Sell rating(s)	19 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.36

In the previous week, Tesla had 189 more articles in the media than Abbott Laboratories. MarketBeat recorded 244 mentions for Tesla and 55 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.41 beat Tesla's score of 0.96 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tesla	165 Very Positive mention(s)	26 Positive mention(s)	33 Neutral mention(s)	17 Negative mention(s)	3 Very Negative mention(s)	Positive

Abbott Laboratories has higher earnings, but lower revenue than Tesla. Abbott Laboratories is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78
Tesla	$94.83B	15.86	$3.79B	$1.09	367.42

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 66.2% of Tesla shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 19.9% of Tesla shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Abbott Laboratories beats Tesla on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to AbbVie?

Abbott Laboratories (NYSE:ABT) and AbbVie (NYSE:ABBV) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Abbott Laboratories presently has a consensus target price of $118.30, indicating a potential upside of 33.71%. AbbVie has a consensus target price of $253.43, indicating a potential upside of 16.99%. Given Abbott Laboratories' higher probable upside, equities research analysts clearly believe Abbott Laboratories is more favorable than AbbVie.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85
AbbVie	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.88

Abbott Laboratories has a beta of 0.63, indicating that its share price is 37% less volatile than the broader market. Comparatively, AbbVie has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market.

Abbott Laboratories has higher earnings, but lower revenue than AbbVie. Abbott Laboratories is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78
AbbVie	$61.16B	6.26	$4.23B	$2.03	106.71

Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.8%. AbbVie pays an annual dividend of $6.92 per share and has a dividend yield of 3.2%. Abbott Laboratories pays out 70.6% of its earnings in the form of a dividend. AbbVie pays out 340.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 54 consecutive years and AbbVie has raised its dividend for 53 consecutive years.

Abbott Laboratories has a net margin of 13.90% compared to AbbVie's net margin of 5.79%. Abbott Laboratories' return on equity of 17.62% beat AbbVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
AbbVie	5.79%	-576.45%	13.39%

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 70.2% of AbbVie shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.1% of AbbVie shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, AbbVie had 7 more articles in the media than Abbott Laboratories. MarketBeat recorded 62 mentions for AbbVie and 55 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.41 beat AbbVie's score of 1.19 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AbbVie	49 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Abbott Laboratories beats AbbVie on 12 of the 20 factors compared between the two stocks.

How does Abbott Laboratories compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

In the previous week, Abbott Laboratories had 5 more articles in the media than Boston Scientific. MarketBeat recorded 55 mentions for Abbott Laboratories and 50 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.52 beat Abbott Laboratories' score of 1.41 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Boston Scientific has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Boston Scientific presently has a consensus target price of $85.08, indicating a potential upside of 87.81%. Abbott Laboratories has a consensus target price of $118.30, indicating a potential upside of 33.71%. Given Boston Scientific's higher possible upside, research analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78

Boston Scientific has a net margin of 17.29% compared to Abbott Laboratories' net margin of 13.90%. Boston Scientific's return on equity of 19.17% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Abbott Laboratories	13.90%	17.62%	10.01%

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABT vs. The Competition

Export

Metric	Abbott Laboratories	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$153.99B	$8.34B	$6.43B	$23.21B
Dividend Yield	2.85%	2.55%	2.68%	4.06%
P/E Ratio	24.78	15.57	24.75	31.61
Price / Sales	3.48	7.37	529.99	112.15
Price / Cash	12.65	17.05	45.07	24.44
Price / Book	2.92	3.28	10.80	4.68
Net Income	$6.52B	$224.06M	$3.57B	$1.08B
7 Day Performance	0.67%	-1.92%	0.72%	-0.82%
1 Month Performance	0.87%	-2.90%	0.41%	1.07%
1 Year Performance	-33.42%	0.83%	29.34%	25.02%

Abbott Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABT Abbott Laboratories	4.9861 of 5 stars	$88.48 +0.1%	$118.30 +33.7%	-33.4%	$153.99B	$44.33B	24.78	115,000	Positive News Dividend Announcement Analyst Downgrade High Trading Volume
DXCM DexCom	4.5793 of 5 stars	$74.22 -1.5%	$84.83 +14.3%	-9.4%	$29.08B	$4.66B	31.72	11,000	Positive News Insider Trade
ISRG Intuitive Surgical	4.3099 of 5 stars	$416.55 +1.3%	$571.28 +37.1%	-20.1%	$145.58B	$10.06B	50.49	17,021	Positive News
TSLA Tesla	3.1351 of 5 stars	$411.15 +1.2%	$404.37 -1.6%	+24.3%	$1.53T	$94.83B	377.20	134,785	Trending News Analyst Forecast
ABBV AbbVie	4.6601 of 5 stars	$221.42 -2.8%	$253.43 +14.5%	+17.0%	$402.35B	$61.16B	109.07	57,000	Trending News Dividend Announcement Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ABT) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Summary

How does Abbott Laboratories compare to Tesla?

Summary

How does Abbott Laboratories compare to AbbVie?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Which has stronger valuation & earnings, DXCM or ABT?

Does the media refer more to DXCM or ABT?

Which has more risk & volatility, DXCM or ABT?

Do analysts rate DXCM or ABT?

Do institutionals & insiders hold more shares of DXCM or ABT?

Is DXCM or ABT more profitable?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Which has more risk and volatility, ABT or ISRG?

Is ABT or ISRG more profitable?

Which has higher valuation and earnings, ABT or ISRG?

Do analysts rate ABT or ISRG?

Do insiders and institutionals hold more shares of ABT or ISRG?

Does the media refer more to ABT or ISRG?

Summary

How does Abbott Laboratories compare to Tesla?

Which has more volatility and risk, ABT or TSLA?

Is ABT or TSLA more profitable?

Do analysts prefer ABT or TSLA?

Does the media refer more to ABT or TSLA?

Which has stronger valuation and earnings, ABT or TSLA?

Do institutionals and insiders hold more shares of ABT or TSLA?

Summary

How does Abbott Laboratories compare to AbbVie?

Do analysts rate ABT or ABBV?

Which has more volatility & risk, ABT or ABBV?

Which has preferable earnings & valuation, ABT or ABBV?

Is ABT or ABBV a better dividend stock?

Is ABT or ABBV more profitable?

Do insiders & institutionals believe in ABT or ABBV?

Does the media refer more to ABT or ABBV?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Does the media prefer BSX or ABT?

Do insiders and institutionals hold more shares of BSX or ABT?

Which has more risk & volatility, BSX or ABT?

Do analysts rate BSX or ABT?

Which has higher earnings and valuation, BSX or ABT?

Is BSX or ABT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools